Yokoi T - Search Results

1

Nicotine metabolism and CYP2A6 allele frequencies in Koreans.

Kwon JT, Nakajima M, Chai S, Yom YK, Kim HK, Yamazaki H, Sohn DR, Yamamoto T, Kuroiwa Y, Yokoi T. Kwon JT, et al. Among authors: yokoi t. Pharmacogenetics. 2001 Jun;11(4):317-23. doi: 10.1097/00008571-200106000-00006. Pharmacogenetics. 2001. PMID: 11434509

2

Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans.

Nakajima M, Yamagishi S, Yamamoto H, Yamamoto T, Kuroiwa Y, Yokoi T. Nakajima M, et al. Among authors: yokoi t. Clin Pharmacol Ther. 2000 Jan;67(1):57-69. doi: 10.1067/mcp.2000.103957. Clin Pharmacol Ther. 2000. PMID: 10668854 Clinical Trial.

3

Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.

Nakajima M, Kwon JT, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, Yamazaki H, Yamamoto T, Kuroiwa Y, Yokoi T. Nakajima M, et al. Among authors: yokoi t. Clin Pharmacol Ther. 2001 Jan;69(1):72-8. doi: 10.1067/mcp.2001.112688. Clin Pharmacol Ther. 2001. PMID: 11180041

4

CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.

Fukami T, Nakajima M, Sakai H, McLeod HL, Yokoi T. Fukami T, et al. Among authors: yokoi t. Pharmacogenomics J. 2006 Nov-Dec;6(6):401-12. doi: 10.1038/sj.tpj.6500390. Epub 2006 Apr 25. Pharmacogenomics J. 2006. PMID: 16636685

5

Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.

Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y. Nakajima M, et al. Among authors: yokoi t. J Pharmacol Exp Ther. 1996 May;277(2):1010-5. J Pharmacol Exp Ther. 1996. PMID: 8627511

6

Role of human cytochrome P4502A6 in C-oxidation of nicotine.

Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y. Nakajima M, et al. Among authors: yokoi t. Drug Metab Dispos. 1996 Nov;24(11):1212-7. Drug Metab Dispos. 1996. PMID: 8937855

7

Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.

Yamazaki H, Shibata A, Suzuki M, Nakajima M, Shimada N, Guengerich FP, Yokoi T. Yamazaki H, et al. Among authors: yokoi t. Drug Metab Dispos. 1999 Nov;27(11):1260-6. Drug Metab Dispos. 1999. PMID: 10534310

8

Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs.

Nakajima M, Nakamura S, Tokudome S, Shimada N, Yamazaki H, Yokoi T. Nakajima M, et al. Among authors: yokoi t. Drug Metab Dispos. 1999 Dec;27(12):1381-91. Drug Metab Dispos. 1999. PMID: 10570018

9

Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds.

Nakajima M, Suzuki M, Yamaji R, Takashina H, Shimada N, Yamazaki H, Yokoi T. Nakajima M, et al. Among authors: yokoi t. Xenobiotica. 1999 Dec;29(12):1191-202. doi: 10.1080/004982599237877. Xenobiotica. 1999. PMID: 10647906

10

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.

Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T. Katoh M, et al. Among authors: yokoi t. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):843-52. doi: 10.1007/s002280050706. Eur J Clin Pharmacol. 2000. PMID: 10805063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,305 results

Search Page

Filters